Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market is expected to grow with the CAGR of 10.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario. The major players dealing in Kirsten Rat Sarcoma (KRAS) market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
Thermo Fisher Scientific Inc., is dominating player in Kirsten Rat Sarcoma (KRAS) market. The other key players existing in the market includes Abbott, Agilent Technologies, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Merck KGaA, EntroGen, Inc., ViennaLab Diagnostics GmbH, Sysmex Inostics, DiaCarta, Takara Bio Inc., Illumina, Inc., Amoy Diagnostics Co., Ltd., Agena Bioscience, Inc., Proteintech Group, Inc., Biocartis among others.
Thermo Fisher Scientific Inc., headquartered in Massachusetts, U.S. was founded in 2006. The company engages in the development, manufacture, marketing and sale of medical devices. The company offers Laboratory Supplies, Laboratory Equipment, Laboratory Instruments, Clinical & Diagnostics, Chromatography & Mass Spectrometry, Cell Culture, Protein and Cell Analysis, Molecular Biology & Nucleic Acid Analysis, Sequence-Specific Nucleic Acid Products. The company has presence in North America, Europe, and Asia-Pacific. The company has various subsidiaries that are Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited1 (New Zealand) among others.
Illumina, Inc is headquartered in San Diego, U.S. and was founded in 1998. The company is a leading developer, manufacturer and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers Clinical Research Products, Sequencing Reagents and Flow Cells, In Vitro Diagnostic (IVD) Products, Molecular Biology Reagents, Library Preparation Kits, Software and Informatics, Microarray Kits. The company has presence in Americas, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries that are Bluebee Holding B.V. (Netherlands), Genologics (Canada), GRAIL (California), Advanced Liquid Logic (U.S.) among others.
Abbott is headquartered in Illinois, U.S. And was founded in 1888. The company is focused on providing the good health to the people around the world through their innovative medicines and technologies. The company offers Consumers and Health Professionals. The company has a presence in Asia-Pacific, Europe, Middle East and Africa, Americas. The company has various subsidiaries that are Alere Inc. (U.S.), Panbio Ltd (Australia), Abbott India Ltd (Mumbai), Abbott Japan Co., Ltd. (Japan), Abbott Canada (Canada) among others.
Global Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2027
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2028
Europe Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2028